Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

UNKNOWN 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 96Inflammatory Breast Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 8Breast Neoplasms, Male 6Breast Carcinoma In Situ 6Neoplasm Metastasis 4Triple Negative Breast Neoplasms 3Neoplasms 3Locally Advanced Breast Cancer 2Colorectal Neoplasms 2Breast Cancer Patients 2Stress, Psychological 1Postoperative Complications 1Pathologic Complete Response 1Neovascularization, Pathologic 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Motor Activity 1Margins of Excision 1Inflammation 1Infertility 1High-Risk Cancer 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer 1Colonic Neoplasms 1Cardiotoxicity 1Carcinoma, Lobular 1Breast Cancer-specific Survival 1Breast Cancer Metastatic 1Breast Cancer Invasive 1

Interventions

Trastuzumab 5Carboplatin 5Docetaxel 4pertuzumab 3Paclitaxel 3Cyclophosphamide 3pembrolizumab 2Epirubicin 2Doxorubicin 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1taxane 1talazoparib 1sarilumab 1pyrotinib 1pirarubicin 1pexidartinib 1patritumab 1olaparib 1niraparib 1neratinib 1ganitumab 1durvalumab 1dostarlimab 1cemiplimab 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Neoadjuvant Therapy × Breast × Clear all
NCT05441098 2022-07-01

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

ChineseAMS

Unknown
1,821 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡